Medical News

RSS

Virginia Tech participates in national effort to combat concussions

Virginia Tech is participating in a new, landmark $30 million national effort sponsored by the National Collegiate Athletic Association and the U.S. Department of Defense to combat concussions among college athletes and active service military personnel.

26 Sep 2014

Universal Health Services acquires Cygnet Health Care, added as component of S&P 500 Index

Universal Health Services, Inc. announced today that it has acquired the stock of Cygnet Health Care Limited ("Cygnet") for a purchase price of approximately $335 million.

26 Sep 2014

Four more hospital systems quit ACO program

Three years after the Centers For Medicare & Medicaid Services selected 32 groups to participate in the Pioneer Accountable Care Organization Model program, they are down to 19 players.

26 Sep 2014

MIT researchers use disarmed version of anthrax toxin to deliver cancer drugs

Bacillus anthracis bacteria have very efficient machinery for injecting toxic proteins into cells, leading to the potentially deadly infection known as anthrax. A team of MIT researchers has now hijacked that delivery system for a different purpose: administering cancer drugs.

26 Sep 2014

Abbott acquires CFR Pharmaceuticals; declares results of tender offer for CFR's ordinary shares

Abbott has acquired control of CFR Pharmaceuticals, more than doubling its Latin American branded generics pharmaceutical presence and further expanding the company's presence in fast-growing markets.

26 Sep 2014

Underinsured Obamacare enrollees flood community health centers

Some low-income consumers who bought bronze plans with low premiums but high deductibles are discovering they still can't afford health care and are turning to the community health centers which can not turn anyone away.

26 Sep 2014

Imperial scientists map proteins affected by NMT enzyme, suggest potential way to treat cancer

Imperial chemists have gained fresh insights into how a disease-causing enzyme makes changes to proteins and how it can be stopped.

26 Sep 2014

Allegheny Health Network, Highmark Health commemorate opening of Health + Wellness Pavilion in Wexford

Officials and employees of Highmark Health and Allegheny Health Network today joined community leaders and public officials to celebrate the planned October 1 grand opening of the Network's new Health + Wellness Pavilion in Wexford.

26 Sep 2014

CHLA achieves Accredited Pediatric Heart Failure Institute designation

Children's Hospital Los Angeles was honored by The Healthcare Colloquium as the first west coast pediatric hospital to achieve designation as an Accredited Pediatric Heart Failure Institute.

26 Sep 2014

Prevalence of NTDs in Latin American countries presents opportunity for US foreign policy

Recently published prevalence estimates of neglected tropical diseases (NTDs) in five Latin American countries - Bolivia, Cuba, Ecuador, Nicaragua and Venezuela - could suggest a new direction for United States foreign policy in the region, according to a tropical-disease expert at Rice University's Baker Institute for Public Policy.

26 Sep 2014

Gastric bypass surgery provides better results than gastric banding

Gastric bypass surgery has better outcomes than gastric banding for long-term weight loss, controlling type 2 diabetes and high blood pressure, and lowering cholesterol levels, according to a new review by UT Southwestern Medical Center surgeons of nearly 30 long-term studies comparing the two types of bariatric procedures.

26 Sep 2014

UMass Amherst cell biologists propose new detailed cytokinesis model

Along with copying and splitting DNA during division, cells must have a way to break safely into two viable daughter cells, a process called cytokinesis. But the molecular basis of how plant cells accomplish this without mistakes has been unclear for many years.

26 Sep 2014

Australian researchers use hookworms to reduce symptoms of celiac disease

Australian researchers have achieved groundbreaking results in a clinical trial using hookworms to reduce the symptoms of celiac disease.

26 Sep 2014

Researchers develop new strategy for reducing serious side effects of modern anticancer drugs

An interdisciplinary team of researchers from the University of Vienna (Institute of Inorganic Chemistry) and the Medical University of Vienna (Institute for Cancer Research) has successfully developed a new strategy for reducing the often serious side effects of an important class of modern anticancer drugs (tyrosine kinase inhibitors).

26 Sep 2014

Scientists discover new clues about drug used in treating blood cancer

Keck Medicine of USC scientists have discovered new clues about a drug instrumental in treating a certain blood cancer that may provide important targets for researchers searching for cures.

26 Sep 2014

Survey: More than 70% of young cancer specialists across Europe show signs of burnout

Across Europe, more than 70% of young cancer specialists are showing signs of burnout, the largest survey of its kind has revealed. The results, reported at the Congress of the European Society for Medical Oncology (ESMO 2014) in Madrid, have prompted calls for serious action to address the issue at all levels.

26 Sep 2014

GSA and NAM select reporters for Journalists in Aging Fellows Program

The Gerontological Society of America (GSA) and New America Media (NAM) have selected 19 reporters for the Journalists in Aging Fellows Program, now in its fifth year.

26 Sep 2014

Dramatic videos of OSA patients increase CPAP usage

Like more than 20 million other Americans, John Brugger has been diagnosed with sleep apnea. He snored, tossed and turned and struggled to breathe during the night, which often left him not only exhausted the next day but also raised his risk of heart attack, stroke and car accidents.

26 Sep 2014

MicroBiome Therapeutics' NM 505 drug can improve tolerability of metformin

MicroBiome TherapeuticsTM LLC, today reported positive topline results from a proof of concept study testing whether its investigational drug, NM 505, can improve the tolerability of metformin, the first-line therapy for Type 2 diabetes worldwide.

26 Sep 2014

AcelRx plans for resubmission of Zalviso NDA

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today provided an update on the plans for the resubmission of the Company's New Drug Application (NDA) for Zalviso (sufentanil sublingual tablet system).

26 Sep 2014

Medical News

Virginia Tech participates in national effort to combat concussions

Universal Health Services acquires Cygnet Health Care, added as component of S&P 500 Index

Four more hospital systems quit ACO program

MIT researchers use disarmed version of anthrax toxin to deliver cancer drugs

Abbott acquires CFR Pharmaceuticals; declares results of tender offer for CFR's ordinary shares

Underinsured Obamacare enrollees flood community health centers

Imperial scientists map proteins affected by NMT enzyme, suggest potential way to treat cancer

Allegheny Health Network, Highmark Health commemorate opening of Health + Wellness Pavilion in Wexford

CHLA achieves Accredited Pediatric Heart Failure Institute designation

Prevalence of NTDs in Latin American countries presents opportunity for US foreign policy

Gastric bypass surgery provides better results than gastric banding

UMass Amherst cell biologists propose new detailed cytokinesis model

Australian researchers use hookworms to reduce symptoms of celiac disease

Researchers develop new strategy for reducing serious side effects of modern anticancer drugs

Scientists discover new clues about drug used in treating blood cancer

Survey: More than 70% of young cancer specialists across Europe show signs of burnout

GSA and NAM select reporters for Journalists in Aging Fellows Program

Dramatic videos of OSA patients increase CPAP usage

MicroBiome Therapeutics' NM 505 drug can improve tolerability of metformin

AcelRx plans for resubmission of Zalviso NDA

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Membrane proteins in focus: Turning high-risk targets into routine workflows

Latest News